Merlin Biosciences has been under the cloud of an investigation by the UK's Serious Fraud Office. Now founder Chris Evans says the firm is planning new investments.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.